CrossRef 2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer

Statistics. Cancer J Clin 2008, 58:71–96.CrossRef 3. Niessen RC, Berends MJW, Wu Y, Sijmons RH, Hollema H, Ligtenberg MJL, deWalle HEK, de Vries EGE, Karrenbeld A, Buys CHCM, van der Zee AGJ, Hofstra RMW, Kleibeuker JH: Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated CHIR-99021 price with hereditary non-polyposis colorectal cancer. Gut 2006, 55:1781–1788.PubMedCrossRef 4. Liya G, Hong Y, McCulloch S, Watanabe H, Li G-M: ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair. Nucleic Acids Research 1998, 26:1173–1178.CrossRef 5. Yamasaki Y, Matsushima M, Tanaka H, Tajiri S, Fukuda R, Ozawa H, Takagi A, Hirabayashi K, Sadahiro S: Patient with Eight Metachronous Gastrointestinal Cancers Thought to be Hereditary Nonpolyposis Colorectal Cancer (HNPCC). Inter Med 2010, 49:209–213.CrossRef 6.

Learn PA, Kahlenberg MS: Hereditary mTOR inhibitor Colorectal Cancer Syndromes and the Role of the Surgical Oncologist. Surg Oncol Clin N Am 2008, 18:121–144.CrossRef 7. Fields JZ, Gao Z, Gao Z, Lewis M, Maimonis P, Harvey J, Lynch HT, Boman BM: Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer. The Journal of Laboratory and Clinical Medicine 2004, 143:59–66.PubMedCrossRef 8. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248–254.PubMedCrossRef 9. Agarwal R, Mumtaz H, Ali N: Role of inositol polyphosphates in programmed cell death. Celastrol Mol Cell Biochem 2009, 328:155–165.PubMedCrossRef 10. Parsons R, Li GM, Longley M, Modrich P, Liu B, Berk T, Hamilton SR, Kinzler KW, Vogelstein B: Mismatch repair deficiency in phenotypically normal human cells. Science 1995, 268:738–740.PubMedCrossRef

11. Coolbaugh-Murphy M, Xu JP, Ramagli LS, Ramagli BC, Brown BW, Lynch PM, Hamilton SR, Frazier L, Siciliano MJ: Microsatellite instability in the peripheral blood leukocytes of HNPCC patients. Human Mutation 2010, 31:317–324.PubMedCrossRef 12. Marra G, D’Atri S, Corti C, Bonmassar L, Cattaruzza MS, Schweizer P, Heinimann K, Bartosova Z, Nystrom-Lahti M, Jiricny J: Tolerance of human MSH21/2 lymphoblastoid cells to the methylating agent temozolomide. Proc Natl Acad Sci USA 2001, 98:7164–7169.PubMedCrossRef 13. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Pifithrin�� Comeras I, de la Chapelle A: Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008, 26:5783–8.PubMedCrossRef Competing interests The authors declare that they have no competing interests.